Condition

EGFR C797S

ClinicalTrials.gov condition label

Clinical trials2

Recruiting0

Common interventions5

Lead sponsors shown1

Clinical trials

2 shown

(HARMONY) Study of BLU-701 in EGFR-mutant NSCLCNCT05153408 · 2022-01-13

TERMINATED

(SYMPHONY) Phase 1/2 Study Targeting EGFR Resistance Mechanisms in NSCLCNCT04862780 · 2021-06-29

TERMINATED

Common interventions

osimertinibDRUG2BLU-701DRUG1BLU-945DRUG1carboplatinDRUG1pemetrexedDRUG1

Leading sponsors

Blueprint Medicines Corporation2

Trial status mix

TERMINATED2

Phase mix

PHASE12

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.